Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II MenAC Conjugate Vaccine in Infants
CTR20170724Phase 2Active
- Sponsor
- Sinopharm
- Start
- Jul 2017
- Modality
- Split/Subunit Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of meningococcal A+C conjugate vaccine in meningococcal meningitis, sponsored by Sinopharm. Started Jul 2017; status: active.
02
Drugs
meningococcal A+C conjugate vaccine
03
Conditions
meningococcal meningitis
Beyond the preview
Go deeper on CTR20170724.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20170724.